Celecoxib
5 Inquiries
169590-42-5
Pharmaceutical Grade
99%
Any China Port
1kg/as customer's requirment
2020-06-29
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Celecoxib
Other Name:Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;Celecoxib;SC 58635;YM 177;Celebrex;Celocoxib;Celebra;Celecox;Xilebao;Medicoxib;Eurocox;Onsenal;4-[5-(p-Tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;184007-95-2;194044-54-7
CAS No.:169590-42-5
Molecular Formula:C17H14F3N3O2S
InChIKeys:InChIKey=RZEKVGVHFLEQIL-UHFFFAOYSA-N
Molecular Weight:381.37
Exact Mass:381.37
EC Number:200-001-8
UNII:JCX84Q7J1L
NSC Number:758624|719627
DSSTox ID:DTXSID0022777
NCI Thesaurus Code:C1728
Color/Form:Pale yellow solid
ATC Code:L01XX33|M01AH01|L - Antineoplastic and immunomodulating agents|M - Musculo-skeletal system
HScode:2935009090
Categories:
Characteristics-
PSA:
86.4
XLogP3:3.4
Appearance:white to off-white
Density:1.4±0.1 g/cm3
Melting Point:157-159 °C
Boiling Point:529.0±60.0
Flash Point:273.7±32.9 °C
Refractive Index:1.606
Water Solubility:DMSO: >20mg/mL
Storage Conditions:Store at RT
Vapor Pressure:1.2X10-9 mm Hg at 25 deg C /Estimated/
PKA:11.1None
Henrys Law Constant:Henry's Law constant = 7.75X10-13 atm-cu m/mol at 25 °C (est)
Dissociation Constants:11.1|pKa = 11.1 (sulfonamide moiety)
Collision Cross Section:186.4 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]|186.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Experimental Properties:Hydroxyl radical reaction rate constant = 1.45X10-11 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Celecoxib
100 KG Oct 27, 2025
Pakistan
Celecoxib Usp
200 KG May 13, 2025
Pakistan
Celecoxib
50 KG Sep 24, 2025 
India
Celecoxib
100 G Jan 18, 2024 
Finland
Celecoxib
500 G Jul 3, 2023 Post an enquiry for this product